Lee Ainslie’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Lee Ainslie's NVS Position: Q2 2026 in Review
Lee Ainslie increased its Novartis (NVS) stake by 82% in Q2 2026, buying an estimated $1.88M and bringing the position to 27,789 shares worth $4.36M. The position accounts for 0.04% of the portfolio, ranked #53.
Lee Ainslie first reported a position in NVS in Q2 2013 and has held it in 14 quarters since. The position peaked at $61.7M in Q3 2013. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Lee Ainslie held 27,789 shares of Novartis worth $4.36M as of Q2 2026.
- Lee Ainslie bought 12,542 Novartis shares in Q2 2026, an estimated $1.88M.
- Novartis made up 0.04% of Lee Ainslie's portfolio in Q2 2026, its #53 holding.
- Lee Ainslie first reported a position in Novartis in Q2 2013 and has held it in 14 quarters since.
- Lee Ainslie's Novartis position peaked at $61.7M in Q3 2013.
- 1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.